NCT05481346

Brief Summary

The current study aims to determine the effect of a multidomain intervention (physical fitness, motivational and cognitive training) on body composition, sarcopenia, cardiovascular health, physical fitness, functional capacity, quality of life, frailty, emotional state and cognitive status in elderly participants, through a randomized controlled trial, to determine its suitability and recommend it as a preventive and health strategy for community-dwelling older adults.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

July 28, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 1, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 18, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

August 2, 2022

Status Verified

July 1, 2022

Enrollment Period

2 months

First QC Date

July 28, 2022

Last Update Submit

July 31, 2022

Conditions

Keywords

older adultsHealthy agingResistance trainingcognitive trainingcardiovascular training

Outcome Measures

Primary Outcomes (5)

  • Body Weight in Kilograms

    was measured after removal of shoes and heavy outer clothing, using a Tanita BC-418 MA or InBody equipment to the nearest 0.1 kg.

    Change from Baseline body weight (kg) at 18 weeks

  • Height in Meters

    Standing height without shoes was measured using a Seca 202 stadiometer (Seca, Hamburg, Germany) to the nearest 0.1 cm.

    Change from Baseline standing height (cm) at 18 weeks

  • Body Mass Index (BMI)

    was calculated as the ratio of weight to squared height in kg/m\^2

    Change from Baseline Body Mass Index (BMI): (kg/m^2) at 18 weeks

  • % Fat Mass

    % fat mass was measured after removal of shoes and heavy outer clothing, using a Tanita BC-418 MA or InBody equipment to the nearest 0.1 kg.

    Change from Baseline bioelectrical impedance % fat mass at 18 weeks

  • Muscle quality sarcopenia

    Sarcopenia will be assessed taking into account the reference values established for muscle quality. The muscle quality will be measure by hand grip strength test. This test will be performance with manual dynamometry (TKK 5401; Scientific Instruments Co., Ltd., Tokyo, Japan). Maximal isometric upper limb strength will be performance by maximal isometric strength. Upper strength will be register by kilogrammes. Higher value show high strength.

    Change from Baseline to 18 weeks

Secondary Outcomes (16)

  • Change Blood pressure

    Change from Baseline to 18 weeks

  • Change Chair stand test

    Change from Baseline to 18 weeks

  • Change Upper and Lower strength

    Change from Baseline to 18 weeks

  • Health-related quality

    Change from Baseline to 18 weeks

  • Cardiorrespiratory 6 minutes walk test

    Change from Baseline to 18 weeks

  • +11 more secondary outcomes

Study Arms (2)

Multidomain training group

EXPERIMENTAL

Participants will use free weights and functional materials to work the main muscle groups. In addition, they will perform cardiorespiratory training and cognitive training with proposed tasks. Participants will follow the planned training progression. The researchers will record the number of sets completed and the load lifted for each exercise for each participant and the perception of effort in each class.

Procedure: Multidomain training

Control group

NO INTERVENTION

The control group did not receive a training program and were asked not to modify their physical activity habits.

Interventions

The training program has a duration of 18 weeks with 2 training sessions per week. The training will have a gradual progression of intensity. One day they train two blocks of strength and one block of cognitive exercises and on the second day, they train one block of power, one block of strength+cognitive and one block of aerobic training. All sessions are 60 minutes long (10 minutes of warm-up, 40 minutes of training and 10 minutes of cool-down). Classes are in small groups of no more than 8 members.

Multidomain training group

Eligibility Criteria

Age55 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject has provided written and dated informed consent to participate in the study.
  • Subject is a male or female between 55 and 90 years of age, inclusive.
  • Subject is in good health as determined by a health history questionnaire and has been provided clearance from their personal physician.
  • Subject is untrained in resistance and aerobic exercise (does not participate in structured physical activity, including walking, more than 3 times per week).
  • Ability to walk independently without any gait aid

You may not qualify if:

  • Perform high-intensity aerobic exercise on a consistent basis (\>180 min-week).
  • Be performing some other regular and systematic strength training program during the intervention in the first half of 2022.
  • Have a body mass index greater than 35.
  • Have a diagnosis of ischemic heart disease.
  • Have a diagnosis of severe aortic stenosis, uncontrolled arrhythmias, decompensated heart failure or acute myocarditis.
  • Possess uncontrolled blood pressure (TAS \>180 and TAD \>110).
  • Stroke.
  • Severe peripheral arterial disease.
  • Other illnesses such as recent thromboembolic disease, aortic aneurysm, clinically significant renal or hepatic insufficiency, severe COPD, clinically significant acute infections, severe psychiatric illness, uncontrolled metabolic disease, limiting locomotor pathology or musculoskeletal disease worsened by exercise, hormone therapy at the time or one year prior, being a woman with surgical menopause.
  • Other pathologies that contraindicate the practice of physical exercise, collected in the previous medical examination that all participants must undergo.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pablo Jorge Marcos Pardo

Almería, Spain

RECRUITING

MeSH Terms

Conditions

SarcopeniaMemory DisordersMuscular AtrophyCardiovascular DiseasesFrailty

Condition Hierarchy (Ancestors)

Neuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsNeurobehavioral ManifestationsPathologic Processes

Study Officials

  • Pablo Jorge Marcos Pardo, PhD

    Universidad de Almeria

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Pablo Jorge Marcos Pardo, PhD

CONTACT

Pablo Jorge Marcos Pardo, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to an experimental group that will perform the physical exercise program and a control group that will perform nothing and continue with their normal lifestyle routines, without any physical activity.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

July 28, 2022

First Posted

August 1, 2022

Study Start

July 28, 2022

Primary Completion

September 18, 2022

Study Completion

December 30, 2022

Last Updated

August 2, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Once the data are published, the data can be requested and will be made available to other researchers.

Locations